The Value of Intravenous Iron: Beyond the Cave of Speculation
- PMID: 32253272
- PMCID: PMC7217414
- DOI: 10.1681/ASN.2019121340
The Value of Intravenous Iron: Beyond the Cave of Speculation
Keywords: Hemodialysis hazards; anemia; cardiovascular events; infection.
Comment on
-
Intravenous Iron Dosing and Infection Risk in Patients on Hemodialysis: A Prespecified Secondary Analysis of the PIVOTAL Trial.J Am Soc Nephrol. 2020 May;31(5):1118-1127. doi: 10.1681/ASN.2019090972. Epub 2020 Apr 6. J Am Soc Nephrol. 2020. PMID: 32253271 Free PMC article. Clinical Trial.
References
-
- Fishbane S: Iron treatment: Impact of safety issues. Am J Kidney Dis 32[Suppl 4]: S152–S156, 1998 - PubMed
-
- Vaziri ND: Epidemic of iron overload in dialysis population caused by intravenous iron products: A plea for moderation. Am J Med 125: 951–952, 2012 - PubMed
-
- Macdougall IC, White C, Anker SD, Bhandari S, Farrington K, Kalra PA, et al. .; PIVOTAL Investigators and Committees: Intravenous iron in patients undergoing maintenance hemodialysis. N Engl J Med 380: 447–458, 2019 - PubMed
-
- Anker SD, Kirwan BA, van Veldhuisen DJ, Filippatos G, Comin-Colet J, Ruschitzka F, et al. .: Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficient heart failure patients: An individual patient data meta-analysis. Eur J Heart Fail 20: 125–133, 2018 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical